Re: Is patient travel distance associated with survival on phase II clinical trials in oncology? (multiple letters) [1]

Alvaro Muñoz; Jonathan Samet; Elizabeth B. Lamont

doi:10.1093/jnci/djh065

Re: Is patient travel distance associated with survival on phase II clinical trials in oncology? (multiple letters) [1]

Alvaro Muñoz, Jonathan Samet, Elizabeth B. Lamont

Bloomberg School of Public Health

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	411-412
Number of pages	2
Journal	Journal of the National Cancer Institute
Volume	96
Issue number	5
DOIs	https://doi.org/10.1093/jnci/djh065
State	Published - Mar 3 2004

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1093/jnci/djh065

Cite this

@article{e1ecabb6c11f40c2ab774b5a4c4f1b96,

title = "Re: Is patient travel distance associated with survival on phase II clinical trials in oncology? (multiple letters) [1]",

author = "Alvaro Mu{\~n}oz and Jonathan Samet and Lamont, {Elizabeth B.}",

year = "2004",

month = mar,

day = "3",

doi = "10.1093/jnci/djh065",

language = "English (US)",

volume = "96",

pages = "411--412",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - Re

T2 - Is patient travel distance associated with survival on phase II clinical trials in oncology? (multiple letters) [1]

AU - Muñoz, Alvaro

AU - Samet, Jonathan

AU - Lamont, Elizabeth B.

PY - 2004/3/3

Y1 - 2004/3/3

UR - http://www.scopus.com/inward/record.url?scp=1542378192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542378192&partnerID=8YFLogxK

U2 - 10.1093/jnci/djh065

DO - 10.1093/jnci/djh065

M3 - Letter

C2 - 14996865

AN - SCOPUS:1542378192

SN - 0027-8874

VL - 96

SP - 411

EP - 412

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 5

ER -

Re: Is patient travel distance associated with survival on phase II clinical trials in oncology? (multiple letters) [1]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this